OBJECTIVES: Upon completion of this activity, the participant should be able to:  (1) Identify NCCN guidelines for treatment of gliomas and CNS metastatic disease, (2) Recognize common  presenting signs and symptoms of central nervous system tumors.

PLANNER/MODERATOR DISCLOSURE:  Karen Fink, MD PhD is a researcher for Orbus, Novocure, Denovo Biopharma, CNS Pharmaceuticals, Servier Pharmaceuticals/Agios, and Sumitoma Pharma. Claude Denham, MD, is a consultant for the Cancer Expert Now, Inc. Bruce Mickey, MD, has no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION:  The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For information, please contact Tarah Brown at [email protected]